Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Apr 12.
Published in final edited form as: Lancet Diabetes Endocrinol. 2020 May;8(5):367–368. doi: 10.1016/S2213-8587(20)30106-6

Type 1 diabetes—origins and epidemiology

Sarah G Howard 1, Robert M Sargis 2
PMCID: PMC8040131  NIHMSID: NIHMS1687186  PMID: 32333869

In their Review, Norris and colleagues1 state “Although many toxins have been introduced into the environment, many have been banned resulting in decreasing exposure trends.” However, environmental chemical exposure trends have actually been increasing overall, and are extremely consistent with temporal type 1 diabetes incidence trends.

In the USA and western Europe, the incidence of type 1 diabetes began to increase around the time of World War 2 (1939–45),2 when industrial chemical production in these areas began.3 Since then, industrial chemical production has increased dramatically.3 Before 1939, when type 1 diabetes incidence rates were low, annual synthetic chemical production was also very low. However, by 2005, industrial chemical production had steadily increased to about 250 billion kg per year in the USA,3 and by this time the incidence of type 1 diabetes had also increased.1

Although a handful of individual chemicals have been banned, these bans are largely restricted to some persistent organic pollutants. Environmental and human contamination remain widespread despite persistent organic pollutants declining over recent decades. All pregnant women in the USA have measurable concentrations of numerous chemicals across multiple bodily fluids, including many banned persistent organic pollutants.4 One reason environmental toxicology is so complex to study in humans is that no unexposed populations exist to serve as controls.

More than 350 000 chemicals and mixtures of chemicals are now registered for production and use worldwide, with more new chemicals added annually,5 yet we barely understand the health effects of a few hundred of these chemicals. The vast majority have never been studied for their metabolic toxicity, and almost none have been examined in relation to type 1 diabetes.

Footnotes

We declare no competing interests.

Contributor Information

Sarah G Howard, Diabetes and Environment Program, Commonweal, Bolinas, CA 94924, USA.

Robert M Sargis, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.

References

  • 1.Norris JM, Johnson RK, Stene LC. Type 1 diabetes—early life origins and changing epidemiology. Lancet Diabetes Endocrinol 2020; 8: 226–238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Gale EA. The rise of childhood type 1 diabetes in the 20th century. Diabetes 2002; 51: 3353–61. [DOI] [PubMed] [Google Scholar]
  • 3.Neel BA, Sargis RM. The paradox of progress: environmental disruption of metabolism and the diabetes epidemic. Diabetes 2011; 60: 1838–48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Woodruff TJ, Zota AR, Schwartz JM. Environmental chemicals in pregnant women in the United States: NHANES 2003–2004. Environ Health Perspect 2011; 119: 87885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Wang Z, Walker GW, Muir DCG, Nagatani-Yoshida K. Toward a global understanding of chemical pollution: a first comprehensive analysis of national and regional chemical inventories. Environ Sci Technol 2020; 54: 2575–84. [DOI] [PubMed] [Google Scholar]

RESOURCES